New York doctors testing heated chemo for rare cancer

Mar 05, 2009 By Delthia Ricks

Long Island cancer doctors have borrowed a page from medicine's past to write a new chapter on how to address a rare malignancy by infusing heated chemotherapy directly into the abdomen using a heart-lung machine.

The treatment is being tested at Stony Brook University Medical Center as a therapy for cancer of the appendix, a malignancy so rare it is known as an orphan cancer. The American Cancer Society has no statistics on its prevalence.

Dr. Colette Pameijer, a Stony Brook cancer surgeon and researcher, is treating appendiceal cancer with heated chemotherapy in what she interchangeably calls a "chemo bath" or, more technically, intraperitoneal hyperthermic chemoperfusion.

By warming the cancer drug, mitomycin, to about 107 degrees, it becomes a heated anti-cancer weapon when pumped through a catheter directly into the abdomen after surgery. The chemo bath is performed only once.

"We believe that in addition to the chemotherapy, the heat is directly toxic to the tumor cells," Pameijer said. She added the concept of a chemo bath for cancer of the appendix was first broached about 20 years ago by Dr. Paul Sugarbaker, a Washington cancer specialist and theorist who had researched new ways to approach appendiceal cancer, which can be resistant to chemotherapy.

He found when chemo is heated, its warmth zeros in on a key vulnerability of cancer cells -- they can't stand heat. Weakening the cancer with heat helps make the drug dramatically more effective.

Yet when Sugarbaker first advanced the notion of heat-treating cancer, he was met with a torrent of criticism from the medical establishment.

Pameijer said the therapy is not approved by the U.S. Food and Drug Administration, but she hopes to advance her work in the next two years to a formal nationwide clinical trial. "Not many people have it (appendiceal cancer) so it is difficult to do clinical trials," she said.

"With appendiceal cancer there isn't much funding so, yes, you do have to be a maverick," she said of taking bold steps in treatment strategies.

Cancer of the appendix, however, is not the only one short on research funding, experts say. Pancreatic cancer is another orphan malignancy for which there is little research funding, explained Kerry Kaplan, executive director of the Lustgarten Foundation for Pancreatic Cancer Research in Bethpage, N.Y. She, too, said people with common cancers have more political power as a group and can place more pressure on legislators for funding.

Dorothy Goncalves of Staten Island learned about Pameijer's chemo bath technique through her son and nephew, who are physicians. "I knew I had to have this," she said, adding there were few other treatments.

She said she had the treatment in September and all tests since that time have shown her to be cancer-free. "I just had a PET scan and CT scan and I am clean, no cancer at all."


(c) 2009, Newsday.
Visit Newsday online at
Distributed by McClatchy-Tribune Information Services.

Explore further: Solving cancer's secrets

add to favorites email to friend print save as pdf

Related Stories

Fighting cancer with light

Jan 29, 2010

Gloria Correa has tried all the standard weapons in her war against cancer: chemotherapy, radiation, and finally surgery.

Recommended for you

Solving cancer's secrets

31 minutes ago

Some fathers play ball with their sons. Or take them fishing. Chuck Perou's father took his son to his pathology lab to show him how a pathologist conducts tests and runs experiments. Perou, a nature junky ...

Cancer stem cells linked to drug resistance

20 hours ago

Most drugs used to treat lung, breast and pancreatic cancers also promote drug-resistance and ultimately spur tumor growth. Researchers at the University of California, San Diego School of Medicine have discovered ...

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Mar 05, 2009
Heat INCREASES mitosis rate. Sounds like the opposite of what to do!

More news stories

Scientists make critical end-stage liver discovery

(Medical Xpress)—A team of researchers in the University of Arizona's College of Pharmacy has discovered a molecular pathway that could be key to creating new therapeutics that would slow or even reverse ...

Solving cancer's secrets

Some fathers play ball with their sons. Or take them fishing. Chuck Perou's father took his son to his pathology lab to show him how a pathologist conducts tests and runs experiments. Perou, a nature junky ...

Harm-reduction program optimizes HIV/AIDS prevention

(Medical Xpress)—New research from UC San Francisco and the San Francisco AIDS Foundation has found that clients participating in a harm-reduction substance use treatment program, the Stonewall Project, decrease their use ...

Meth mouth menace

Something was up in Idaho. While visiting a friend in Athol, a small town north of Coeur d'Alene, Jennifer Towers, director of research affairs at the Tufts University School of Dental Medicine, noticed ...